@article{cf65529089a24e4eb76e83a0af48936b,
title = "Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients",
author = "Qin, \{Caroline X.\} and Moore, \{Linda W.\} and Shweta Anjan and Ruth Rahamimov and Sifri, \{Costi D.\} and Ali, \{Nicole M.\} and Morales, \{Megan K.\} and Tsapepas, \{Demetra S.\} and Nikolina Basic-Jukic and Miller, \{Rachel A.\} and Duin, \{David Van\} and Santella, \{Robert N.\} and Wadei, \{Hani M.\} and Shah, \{Pali D.\} and Nikki Gage and Maricar Malinis and Saima Aslam and Eve Todesco and Werbel, \{William A.\} and Avery, \{Robin K.\} and Segev, \{Dorry L.\}",
note = "Funding Information: This research was made possible with the generous support of the Ben-Dov family. This work was supported by grant number K24AI144954 (D.L.S.) from the National Institute of Allergy and Infectious Diseases and by grant gSAN-201C0WW from the Transplantation and Immunology Research Network of the American Society of Transplantation (W.A.W.). Funding Information: D.L.S. received honoraria for consulting and speaking from Sanofi, Novartis, CSL Behring, Jazz Pharmaceuticals, Veloxis, Mallinckrodt, and Thermo Fisher Scientific. R.K.A has received study/grant support from Aicuris, Astellas, Chimerix, Merck, Oxford Immunotec, Qiagen, and Takeda/Shire. S.A. received grant support from the Cystic Fibrosis Foundation, received consulting honoraria from Merck and Gilead, and was an unpaid consultant for BioMX. The other authors declare no conflicts of interest. ",
year = "2021",
month = nov,
day = "1",
doi = "10.1097/TP.0000000000003907",
language = "English (US)",
volume = "105",
pages = "E265--E266",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "11",
}